Harnessing Neuroplasticity of Postural Sensorimotor Networks Using Non-Invasive Spinal Neuromodulation to Maximize Functional Recovery After Spinal Cord Injury

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 6, 2023

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Spinal Cord InjuriesNeuromodulation
Interventions
DEVICE

Transcutaneous Spinal cord Stimulation

Delivered using a constant-current stimulator

DEVICE

Epidural Spinal Stimulation (ESS)

"The device used for ESS, the CoverEdgeX 32 Surgical Lead system (Boston Scientific, USA), is a device approved by the FDA used in the treatment of severe pain and is approved for individuals to manage chronic pain when other treatments have not been effective.~If you are in the ESS group, you will have surgery to have the stimulator placed and the stimulator will be removed at an office visit towards the end of the study."

Trial Locations (1)

77030

RECRUITING

Houston Methodist Hospital, Houston

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

The Methodist Hospital Research Institute

OTHER